ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO1039

Comparison of Mixed-Based vs Animal-Based Low Phosphorus Diet on Hyperphosphatemia in Dialysis Patients: Randomized Clinical Trial

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1302 Health Maintenance, Nutrition, and Metabolism: Clinical


  • Atilano carsi, Ximena, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico
  • Ramirez-Sandoval, Juan Carlos, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, México city, DIStrito federal, Mexico
  • Sánchez, Jorge Alberto, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de México, Mexico
  • Arce santander, Celene V., Lapi Unidad de Hemodiálisis, Ciudad de México, Mexico
  • Cruz, Cristinoc, INCMNSZ, Mexico city, Mexico
  • Tamez Pedroza, Luis, Universidad Autonoma de Baja California, Ciudad de M?xico, Mexico
  • Garcia de Leon, Miguel Angel, Instituto Mexicano del Seguro Social, Distrito Federal, Mexico
  • Espinosa-Cuevas, Angeles, Nacional Medical Science and Nutrition Institute, Mexico, Mexico
  • Correa-Rotter, Ricardo, Institutor Nacional de la Nutricion, Mexico City, Mexico

Dietary P restriction is major component of hyperphosphatemia treatment in dialysis. Bioavailability of vegetable and animal P sources is not taken in consideration.KDIGO recommends to conduct clinical trials with different sources of dietary P. Aim:assess the effect on serum P of 2 low-Pdiets(<1000mg/day;Animal Vs.vegetal+animal) in dialysis patients.


Randomized,multicenter,open-label clinical trial.Subjects on dialysis for>6 mo and P>4.5mg/dL were randomized into a mixed-based(3oz equivalent animal protein+3oz equivalent legumes)vs.animal-based(6oz equivalent animal protein) low P diet with equivalent nutrients (protein=1.3 g/kg/d).Primary outcome was the change in serum P after 12 wks. We excluded patients who modified their dialysis dose, phosphate binder or vitamin D prescription during trial.


56 subjects(38HD,18PD) were randomized. Age,sex,phosphate-binders use and other baseline characteristics were similar between groups. Baseline P values were 5.6±1.6 and 4.9±1.2 in mixed-based and animal-based groups respectively(p=0.06). Mixed-based group had a significant decrease in P after 12 wks of intervention(5.6±1.6 to 5.0±1.3,p=0.04).Animal-based group did not change P significantly(4.9±1.2 to 4.7±1.4,p=0.46).Serum P in the mixed-based and animal-based declined by -0.66(95%CI:-1.39 to -0.04)mg/dL and -0.21(95%IC:-0.81 to 0.38) respectively(p=0.14,Fig).There were no differences between groups in the change of other biochemical parameters.


Dietary P restriction with animal or mixed-based P sources had a similar efficacy to achieve and maintain P concentration in dialysis. Mixed-based group had a non-statistically significant trend to achieve a higher decrease in serum P.